Magnetic Resonance Imaging of Cardiovascular Manifestations Following COVID‐19

Abstract

Globally, over 650 million people have had COVID‐19 due to infection with the SARS‐Cov‐2 virus. Cardiac complications in the acute infectious and early recovery phase were recognized early in the pandemic, including myocardial injury and inflammation. With a decrease in the number of acute COVID‐19 related deaths, there has been increased interest in postacute sequela of COVID‐19 (PASC) and other longer‐term cardiovascular complications. A proportion of patients recovered from COVID‐19 have persistent cardiac symptoms and are at risk of cardiovascular disease. Cardiovascular imaging, including MRI, plays an important role in the detection of cardiovascular manifestations of COVID‐19 in both the acute and longer‐term phases after COVID‐19. The purpose of this review is to highlight the role of cardiovascular imaging in the diagnosis and risk stratification of patients with acute and chronic cardiovascular manifestations of COVID‐19 with a focus on cardiac MRI. Evidence Level 4. Technical Efficacy Stage 3.

Impact on pulmonary, cardiac, and renal function and long-term quality of life after hospitalization for acute respiratory distress syndrome due to COVID-19: Protocol of the Post-COVID Brazil 3 study

“…( 14 ) Cardiac magnetic resonance imaging has demonstrated a high incidence of post-COVID-19 myocardial changes, but most of these studies included outpatients with a follow-up of only 4 months. ( 29 ) Our study aimed to determine the prevalence of long-term cardiac sequelae, such as ventricular dilation and loss of cardiac function, among individuals with severe COVID-19. Furthermore, myocardial fibrosis detected by the delayed gadolinium enhancement technique may be related to prior myocarditis or ischemic events in the acute phase of COVID-19.…”

“…Contudo, a maioria desses estudos inclui pacientes atendidos ambulatorialmente e com seguimento de apenas 4 meses. ( 29 ) Nosso estudo pretende determinar a prevalência de sequelas cardíacas a longo prazo entre indivíduos com COVID-19 grave como dilatação ventricular e com perda de função cardíaca. Ainda, a detecção de fibrose miocárdica por meio da técnica do realce tardio por gadolínio pode estar relacionada à miocardite prévia ou a eventos isquêmicos na fase aguda da COVID-19.…”